Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: This thing should bounce back

This thing should bounce back

posted on Apr 10, 2008 07:17AM

to the low .50's once we find out how the J's monies will eventually get to us.

What has changed? The other licensees came in at 28 mil. (about what we expected) We still can asume the J2.5 payments are in the range of Fujitsu (likely above) Will it be cash? Don't know. "Business resolution" threw out a flag from the moment we saw it. If we received what is logical from the J2.5's, our value as a company will return to where everyone speculated it would be before the Q release. To keep everything fair - the F/U letter can't come out until the Eourpean markets close.

GLTAL again.

Share
New Message
Please login to post a reply